NCT03456492

Brief Summary

Hyponatremia was defined as a serum sodium concentration \<135 mmol/L that occurred at least once during a patient's hospital stay from admission to discharge. Elderly patients with fragility fractures are particularly susceptible to hyponatremia because of their impaired physiology, multiple comorbidities (such as hypocortisolism, hypothyroidism, hepatic cirrhosis, renal disease, and congestive heart failure), polypharmacy (e.g., antihypertensives, antidepressants, and antiepileptics), hospitalization, perioperative fluid restrictions, and homeostatic stress from the fracture itself and the subsequent surgery. The study has 2 parts: Part 1: aims to to find incidence of hyponatremia in sample of 70 elderly patients with fractures around the hip, effect of hyponatremia on mental state of the patients by using Modified Mini-Mental state (3MS) examination and to find mortality rate for 6 months post admission. Part 2: aims to compare sample of 18 elderly hyponatremic patients with fractures around the hip (case group) with sample of 10 elderly normonatremic patients with osteoartharitis of knee or hip who admitted for elective joint replacement (control group) as regards; serum sodium, 3M score, and CSF glutamate to find correlation between the cognitive status assessed by 3M score and CSF glutamate as a biomarker for hyponatremia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 7, 2018

Completed
25 days until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

October 14, 2020

Status Verified

October 1, 2020

Enrollment Period

1 year

First QC Date

February 13, 2018

Last Update Submit

October 10, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • To find correlation between the cognitive status assessed by 3M score and CSF glutamate as a biomarker for hyponatremia.

    baseline

Secondary Outcomes (1)

  • Early diagnosis and treatment of hyponatremia to avoid fractures

    baseline

Study Arms (2)

case

Hyponatremic elderly patients (\>70 years) with hip fractures

Diagnostic Test: serum sodium

control

Normonatremic elderly patients(\>70 years) undergoing joint replacement

Diagnostic Test: serum sodium

Interventions

serum sodiumDIAGNOSTIC_TEST

Serum sodium will be measured on admission, assesment of mental status by Modified Mini-Mental score and measurement of glutamate in CSF sample taken while dripling during spinal anathesia for surgical intervention.

Also known as: 3M score, CSF glutamate
casecontrol

Eligibility Criteria

Age70 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Elderly patients \> 70 years

You may qualify if:

  • Hyponatremic elderly patients \> 70 years with hip fractures (case group) and surgical intervention will be done by spinal anesthesia so; a sample of CSF can be taken.
  • Normonatremic elderly patients \> 70 years undergoing undergoing joint replacement (control group) and surgical intervention will be done by spinal anesthesia so; a sample of CSF can be taken.

You may not qualify if:

  • Age \< 70 years
  • Patients receive general anesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University Hospital

Asyut, Egypt

Location

Related Links

Study Officials

  • Emad Zarief Kamel, MD

    Associate professor of anesthesiology and ICU

    STUDY CHAIR
  • Mohammed Ismail Sedek, MD

    Associate professor of clinical pathology

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

February 13, 2018

First Posted

March 7, 2018

Study Start

April 1, 2018

Primary Completion

April 1, 2019

Study Completion

June 1, 2019

Last Updated

October 14, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations